Having access to large, national-level biobanks with phenotype and genotype datasets for diverse ancestries, which also adhere to key regulatory and privacy standards, are critical to achieving accurate predictive models. This includes tools such as advanced polygenic risk score algorithms (PRSs), which can be used to enable preventative and personalised medicine approaches, including supporting clinical decision-making.
Download white paper to learn about: